ACADIA PHARMACEUTICALS INC
NASDAQ: ACAD (ACADIA Pharmaceuticals Inc.)
Kemas kini terakhir: 14 jam lalu16.87
0.14 (0.84%)
| Penutupan Terdahulu | 16.73 |
| Buka | 16.51 |
| Jumlah Dagangan | 4,541,453 |
| Purata Dagangan (3B) | 1,540,403 |
| Modal Pasaran | 2,807,033,088 |
| Harga / Pendapatan (P/E TTM) | 21.63 |
| Harga / Pendapatan (P/E Ke hadapan) | 22.52 |
| Harga / Jualan (P/S) | 2.89 |
| Harga / Buku (P/B) | 4.67 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 25 Feb 2025 - 3 Mar 2025 |
| Margin Keuntungan | 13.83% |
| Margin Operasi (TTM) | 12.64% |
| EPS Cair (TTM) | 0.780 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 18.30% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 2,897.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 8.55% |
| Nisbah Semasa (MRQ) | 2.29 |
| Aliran Tunai Operasi (OCF TTM) | 202.73 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 221.72 M |
| Pulangan Atas Aset (ROA TTM) | 8.72% |
| Pulangan Atas Ekuiti (ROE TTM) | 27.36% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | ACADIA Pharmaceuticals Inc. | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | 0.63 |
|
Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 0.55% |
| % Dimiliki oleh Institusi | 97.10% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 28.00 (Needham, 65.98%) | Beli |
| Median | 27.50 (63.01%) | |
| Rendah | 27.00 (HC Wainwright & Co., 60.05%) | Beli |
| Purata | 27.50 (63.01%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 17.20 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 07 Nov 2024 | 27.00 (60.05%) | Beli | 17.20 |
| Needham | 07 Nov 2024 | 28.00 (65.98%) | Beli | 17.20 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |